Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000638427 | SCV000759942 | benign | Kabuki syndrome | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000763856 | SCV000894787 | uncertain significance | Kabuki syndrome 1 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004533338 | SCV004113601 | uncertain significance | KMT2D-related disorder | 2023-06-07 | criteria provided, single submitter | clinical testing | The KMT2D c.6518C>T variant is predicted to result in the amino acid substitution p.Ser2173Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.023% of alleles in individuals of South Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/12-49435035-G-A). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |